Reconciling Methodological Paradigms Toward More Accurate Evaluation of Personalized Traditional Chinese Medicine (TCM) Intervention in Standardized Trials: Introducing the TRIPLE-TCM Trial Framework
Therapeutics and Clinical Risk Management · 2025-11 · Volume 21 · 1521-1534
DOI: 10.2147/tcrm.s557457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutics and Clinical Risk Management, 2025-11. Verfasst von Fei-Yi Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, School of International Medical Technology, Shanghai Sanda University, Shanghai, 201209, People's Republic of China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, School of International Medical Technology, Shanghai Sanda University, Shanghai, 201209, People's Republic of China.
- School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, 3083, Australia.
- Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2050, Australia.
- Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, People's Republic of China.
- School of Computing Technologies, RMIT University, Melbourne, VIC, 3000, Australia.
- Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, People's Republic of China.
ORCID-Profile: Fei-Yi Zhao, Russell Conduit, Yuan Xin Lee, Qiang-Qiang Fu, Chin Moi Chow
Zitieren
APA
Zhao, F. Y., Yue, L. P., Xu, P., Conduit, R., Zhang, W. J., Lee, Y. X., Fu, Q. Q., & Chow, C. M. (2025). Reconciling Methodological Paradigms Toward More Accurate Evaluation of Personalized Traditional Chinese Medicine (TCM) Intervention in Standardized Trials: Introducing the TRIPLE-TCM Trial Framework. Therapeutics and Clinical Risk Management, Volume 21, 1521-1534. https://doi.org/10.2147/tcrm.s557457
Vancouver
Zhao FY, Yue LP, Xu P, Conduit R, Zhang WJ, Lee YX, et al. Reconciling Methodological Paradigms Toward More Accurate Evaluation of Personalized Traditional Chinese Medicine (TCM) Intervention in Standardized Trials: Introducing the TRIPLE-TCM Trial Framework. Therapeutics and Clinical Risk Management. 2025;Volume 21:1521-1534. doi:10.2147/tcrm.s557457
BibTeX
@article{Zhao2025,
author = {Zhao, Fei-Yi and Yue, Li-Ping and Xu, Peijie and Conduit, Russell and Zhang, Wen-Jing and Lee, Yuan Xin and Fu, Qiang-Qiang and Chow, Chin Moi},
title = {Reconciling Methodological Paradigms Toward More Accurate Evaluation of Personalized Traditional Chinese Medicine (TCM) Intervention in Standardized Trials: Introducing the TRIPLE-TCM Trial Framework},
journal = {Therapeutics and Clinical Risk Management},
year = {2025},
volume = {Volume 21},
pages = {1521--1534},
doi = {10.2147/tcrm.s557457}
}
EUVIMED